Burden of Rheumatic Heart Disease in Chinese Children and Adolescents versus Adults: An Analysis from the "Global Burden of Disease" Study.

IF 1.9 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Cardiology Pub Date : 2025-06-19 DOI:10.1159/000546878
Chengqiang Lei, Jian Liu, Xiangyong Liu, Zhi Yang
{"title":"Burden of Rheumatic Heart Disease in Chinese Children and Adolescents versus Adults: An Analysis from the \"Global Burden of Disease\" Study.","authors":"Chengqiang Lei, Jian Liu, Xiangyong Liu, Zhi Yang","doi":"10.1159/000546878","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Rheumatic heart disease (RHD) is a globally important public health issue. China, as a populous country, has daunting challenges posed by RHD-related morbidity and mortality in the public health system. Evaluating and comparing the differences in the RHD burden of children and adolescents versus adults in China not only helps optimize domestic prevention and control strategies but also provides a reference for regional practices in RHD control.</p><p><strong>Methods: </strong>Open data from the 2021 Global Burden of Disease database were utilized to analyze the characteristics of the RHD burden of children, adolescents, and adults in China, including changes in morbidity and mortality. Joinpoint was utilized to calculate the average annual percentage change (AAPC). A comprehensive comparative analysis was undertaken on the differences in RHD burden in Chinese children, adolescents, and adults from multiple dimensions such as age, gender, and time.</p><p><strong>Results: </strong>From 1990 to 2021, the number of deaths of RHD in children and adolescents in China exhibited a declining trend compared to that in adults. In terms of the number of incidences, all age groups showed a declining trend except for those aged 55 and above, which manifested an upward trend. The crude incidence and crude mortality rates both declined during the same period, with their AAPC being -0.53 (95% CI: -0.61, -0.46) and -8.13 (95% CI: -8.65, -7.61) for those aged under 20 years, and -1.92 (95% CI: -2.05, -1.80) and -2.98 (95% CI: -3.18, -2.79) for those aged 20 years and above. The incidence and mortality rates had a bearing on patient age, with higher incidence rates observed in children and adolescents and higher mortality rates observed in adults. According to the analysis of gender differences, the incidence of children and adolescents was higher in men, while women always had a higher crude incidence rate (CIR) and mortality rate (CDR) than men (CIR in 2021: 21.31/100,000 for women vs. 20.08/100,000 for men; CDR: 0.05/100,000 for women vs. 0.06/100,000 for men). The mortality rate of adult women was particularly prominent. The number of cases in children and adolescents exhibited a \"W-shaped\" fluctuation, while the adult group showed an \"M-shaped\" trend. The overall CIR and CDR both exhibited a downward trend.</p><p><strong>Conclusion: </strong>The burden of RHD is linked to age and gender, with a high incidence in young people and a high mortality rate in adults. Women are more prone to develop the disease and have a higher risk of mortality. Given China's large and aging population, RHD remains a major public health challenge in China. Effective prevention and control strategies should be underscored.</p>","PeriodicalId":9391,"journal":{"name":"Cardiology","volume":" ","pages":"1-13"},"PeriodicalIF":1.9000,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000546878","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Rheumatic heart disease (RHD) is a globally important public health issue. China, as a populous country, has daunting challenges posed by RHD-related morbidity and mortality in the public health system. Evaluating and comparing the differences in the RHD burden of children and adolescents versus adults in China not only helps optimize domestic prevention and control strategies but also provides a reference for regional practices in RHD control.

Methods: Open data from the 2021 Global Burden of Disease database were utilized to analyze the characteristics of the RHD burden of children, adolescents, and adults in China, including changes in morbidity and mortality. Joinpoint was utilized to calculate the average annual percentage change (AAPC). A comprehensive comparative analysis was undertaken on the differences in RHD burden in Chinese children, adolescents, and adults from multiple dimensions such as age, gender, and time.

Results: From 1990 to 2021, the number of deaths of RHD in children and adolescents in China exhibited a declining trend compared to that in adults. In terms of the number of incidences, all age groups showed a declining trend except for those aged 55 and above, which manifested an upward trend. The crude incidence and crude mortality rates both declined during the same period, with their AAPC being -0.53 (95% CI: -0.61, -0.46) and -8.13 (95% CI: -8.65, -7.61) for those aged under 20 years, and -1.92 (95% CI: -2.05, -1.80) and -2.98 (95% CI: -3.18, -2.79) for those aged 20 years and above. The incidence and mortality rates had a bearing on patient age, with higher incidence rates observed in children and adolescents and higher mortality rates observed in adults. According to the analysis of gender differences, the incidence of children and adolescents was higher in men, while women always had a higher crude incidence rate (CIR) and mortality rate (CDR) than men (CIR in 2021: 21.31/100,000 for women vs. 20.08/100,000 for men; CDR: 0.05/100,000 for women vs. 0.06/100,000 for men). The mortality rate of adult women was particularly prominent. The number of cases in children and adolescents exhibited a "W-shaped" fluctuation, while the adult group showed an "M-shaped" trend. The overall CIR and CDR both exhibited a downward trend.

Conclusion: The burden of RHD is linked to age and gender, with a high incidence in young people and a high mortality rate in adults. Women are more prone to develop the disease and have a higher risk of mortality. Given China's large and aging population, RHD remains a major public health challenge in China. Effective prevention and control strategies should be underscored.

中国儿童、青少年与成人风湿性心脏病负担:来自“全球疾病负担”研究的分析
背景:风湿性心脏病(RHD)是一个全球性的重要公共卫生问题。中国作为一个人口大国,rhd相关的发病率和死亡率给公共卫生系统带来了严峻的挑战。评价和比较中国儿童、青少年与成人RHD负担的差异,不仅有助于优化国内的预防和控制策略,也可为RHD控制的区域实践提供参考。目的:本研究旨在阐明1990 - 2021年中国儿童和青少年RHD年龄和性别负担的时间趋势,并将其与成人RHD负担进行比较。方法:利用2021年全球疾病负担数据库的公开数据,分析中国儿童、青少年和成人RHD负担的特征,包括发病率和死亡率的变化。使用Joinpoint计算平均年变化百分比(AAPC)。从年龄、性别、时间等多个维度对中国儿童、青少年和成人RHD负担的差异进行综合比较分析。结果:从1990年到2021年,中国儿童和青少年RHD死亡人数与成人相比呈下降趋势。就发病率而言,除55岁及以上人士呈上升趋势外,所有年龄组均呈下降趋势。粗发病率和粗死亡率同期均有所下降,20岁以下患者的AAPC分别为-0.53 (95% CI: -0.61, -0.46)和-8.13 (95% CI: -8.65, -7.61), 20岁及以上患者的AAPC分别为-1.92 (95% CI: -2.05, -1.80)和-2.98 (95% CI: -3.18, -2.79)。发病率和死亡率与患者年龄有关,儿童和青少年的发病率较高,成人的死亡率较高。根据性别差异分析,男性儿童和青少年的发病率较高,而女性的粗发病率(CIR)和死亡率(CDR)始终高于男性(2021年CIR:女性21.31/10万比男性20.08/10万;CDR:女性为0.05/100000,男性为0.06/100000)。成年妇女的死亡率尤其突出。儿童和青少年发病数呈“w”型波动,成人发病数呈“m”型波动。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cardiology
Cardiology 医学-心血管系统
CiteScore
3.40
自引率
5.30%
发文量
56
审稿时长
1.5 months
期刊介绍: ''Cardiology'' features first reports on original clinical, preclinical and fundamental research as well as ''Novel Insights from Clinical Experience'' and topical comprehensive reviews in selected areas of cardiovascular disease. ''Editorial Comments'' provide a critical but positive evaluation of a recent article. Papers not only describe but offer critical appraisals of new developments in non-invasive and invasive diagnostic methods and in pharmacologic, nutritional and mechanical/surgical therapies. Readers are thus kept informed of current strategies in the prevention, recognition and treatment of heart disease. Special sections in a variety of subspecialty areas reinforce the journal''s value as a complete record of recent progress for all cardiologists, internists, cardiac surgeons, clinical physiologists, pharmacologists and professionals in other areas of medicine interested in current activity in cardiovascular diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信